101 related articles for article (PubMed ID: 20031788)
1. Preliminary observations from preliminary trial results: have we finally had enough?
Taylor AJ; Nissen SE
Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):54-7. PubMed ID: 20031788
[No Abstract] [Full Text] [Related]
2. Ezetimibe and cancer--an uncertain association.
Drazen JM; D'Agostino RB; Ware JH; Morrissey S; Curfman GD
N Engl J Med; 2008 Sep; 359(13):1398-9. PubMed ID: 18765434
[No Abstract] [Full Text] [Related]
3. At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.
Hamilton-Craig I; Kostner K; Colquhoun D; Woodhouse S
Heart Lung Circ; 2009 Oct; 18(5):343-6. PubMed ID: 19586799
[TBL] [Abstract][Full Text] [Related]
4. Identifying and addressing safety signals in clinical trials.
Fleming TR
N Engl J Med; 2008 Sep; 359(13):1400-2. PubMed ID: 18768938
[No Abstract] [Full Text] [Related]
5. [Statins plus cholesterol resorption inhibitor. LDL goal values attainable].
MMW Fortschr Med; 2002 Sep; 144(38):56. PubMed ID: 12395708
[No Abstract] [Full Text] [Related]
6. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).
Farmer JA
Curr Atheroscler Rep; 2009 Mar; 11(2):82-3. PubMed ID: 19228479
[No Abstract] [Full Text] [Related]
7. Don't mess with the DSMB.
Drazen JM; Wood AJ
N Engl J Med; 2010 Jul; 363(5):477-8. PubMed ID: 20647188
[No Abstract] [Full Text] [Related]
8. Simvastatin + ezetimibe: a combination with no proven advantages.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
[No Abstract] [Full Text] [Related]
9. Ezetimibe plus simvastatin cardiovascular outcomes study program.
Padial LR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904
[TBL] [Abstract][Full Text] [Related]
10. [How sure is the combined lipid lowering?].
Schäfer J
MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
[No Abstract] [Full Text] [Related]
11. Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.
Green A; Ramey DR; Emneus M; Iachina M; Stavem K; Bolin K; McNally R; Busch-Sørensen M; Willenheimer R; Egstrup K; Kesäniemi YA; Ray S; Basta N; Kent C; Pedersen TR
Am J Cardiol; 2014 Nov; 114(10):1518-22. PubMed ID: 25267716
[TBL] [Abstract][Full Text] [Related]
12. More on DSMBs.
Rosenblatt M; Kim PS
N Engl J Med; 2011 May; 364(19):1879-80. PubMed ID: 21561365
[No Abstract] [Full Text] [Related]
13. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and LDL-C goal attainment of ezetimibe 10 mg-simvastatin 20 mg vs. placebo-simvastatin 20 mg in UK-based adults with coronary heart disease and hypercholesterolaemia.
Patel JV; Hughes EA
Int J Clin Pract; 2006 Aug; 60(8):914-21. PubMed ID: 16893434
[TBL] [Abstract][Full Text] [Related]
15. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
17. Reasons to be cautious about cholesterol lowering drugs.
Struthers M
BMJ; 2008 Sep; 337():a1493. PubMed ID: 18768557
[No Abstract] [Full Text] [Related]
18. Utility of ezetimibe.
Ashikaga H; Blumenthal RS; Jones SR
Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
Ballantyne CM; Blazing MA; King TR; Brady WE; Palmisano J
Am J Cardiol; 2004 Jun; 93(12):1487-94. PubMed ID: 15194018
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
